(LEU) Centrus Energy Corp. Company Overview

What does Centrus Energy do?

Centrus Energy Corp. is a nuclear-fuel and enrichment-services company whose strategic importance is larger than its current revenue base. The company supplies low-enriched uranium, natural uranium and related fuel components to commercial nuclear utilities, while its Technical Solutions segment develops and operates advanced uranium-enrichment capabilities for the U.S. government and private customers. Centrus trades on the New York Stock Exchange under LEU and describes itself in its official business overview as a supplier supporting commercial reactors, national security and advanced manufacturing.

Two businesses, one strategic supply-chain problem

The LEU segment is the established commercial engine. It purchases enrichment and uranium components through long-term supply contracts, spot purchases and inventory, then sells them under multi-year utility contracts. Technical Solutions is the strategic growth platform. It includes the American Centrifuge technology, the Piketon, Ohio enrichment facility, high-assay low-enriched uranium production, engineering and advanced manufacturing. The 2025 Form 10-K identifies the AC100M centrifuge as the only deployment-ready U.S. technology capable of meeting certain national-security enrichment requirements.

How does Centrus Energy make money?

Centrus earns revenue through two different economic models. In LEU, it captures the spread between the cost of uranium and enrichment inputs and the contractual selling price to nuclear utilities. In Technical Solutions, it generally recognizes revenue over time as contract work is performed, including cost-plus-incentive-fee revenue under the Department of Energy HALEU operation contract. These models differ sharply: LEU can produce high gross margins when legacy supply costs and customer contract prices align favorably, while government work can carry lower margins during development, commissioning and undefinitized contract periods.

Which segment matters most today?

For FY2025, LEU generated $346.2 million of revenue and $111.5 million of gross profit, compared with $102.5 million of revenue and $6.0 million of gross profit for Technical Solutions. The result shows why Centrus should not be analyzed as a pure advanced-reactor development company: the commercial fuel business still funds much of the organization. Yet the future strategic value increasingly depends on whether the company converts government awards, contingent customer commitments and manufacturing investment into owned U.S. enrichment capacity.

Why are quarterly results unusually lumpy?

Utility contracts usually have annual purchase commitments rather than smooth quarterly deliveries. Therefore, a low-volume quarter can still have attractive pricing, while a high-volume quarter can carry a different margin depending on the contract mix and inventory cost. This makes backlog, delivery timing, average selling price and average unit cost more informative than a single quarter’s top-line growth.

What did the latest quarter show?

The quarter ended March 31, 2026 showed moderate consolidated revenue growth but a large decline in net income. According to Centrus’s Q1 2026 earnings release, total revenue increased 5% to $76.7 million. Technical Solutions revenue rose 47% to $32.1 million, more than offsetting a 13% decline in LEU revenue to $44.6 million. Gross profit was $31.5 million, down 4%, and net income fell to $10.0 million from $27.2 million.

What changed beneath the headline numbers?

The most important expense signal was advanced technology cost, which increased by $15.9 million year over year. That spending reflects the shift from an asset-light fuel intermediary toward a capital- and engineering-intensive enrichment manufacturer. Investors therefore need to separate accounting earnings from the strategic build-out: near-term costs may rise before commercial production produces corresponding revenue.

Why is HALEU and domestic enrichment central to the strategy?

HALEU contains more uranium-235 than conventional reactor fuel but remains below the threshold for highly enriched uranium. Many proposed advanced reactors require it, yet commercial supply is scarce. Centrus began enrichment operations at Piketon in October 2023 and delivered its first HALEU to DOE in November 2023. This was strategically significant because it demonstrated a U.S.-origin centrifuge technology, an operating workforce and a licensed facility rather than only a laboratory concept.

The turning points that created today’s opportunity

1. 1998
   The United States Enrichment Corporation was privatized, creating the corporate predecessor whose legacy contracts, technology and liabilities still shape Centrus.
2. 2013
   The Paducah gaseous-diffusion plant shut down, leaving the United States without domestic enrichment capability suitable for certain national-security requirements.
3. 2014
   The company completed a restructuring and emerged under the Centrus Energy name, preserving fuel-market relationships while reducing legacy financial pressure.
4. 2019
   A market-related price reset under the TENEX supply contract took effect near historically low SWU prices, materially improving LEU cost economics.
5. 2022
   DOE awarded the HALEU operation contract, funding demonstration and continued operation of the Piketon cascade.
6. 2023
   Centrus started enrichment and made the first delivery of HALEU to DOE, proving the production process.
7. 2025-2026
   The company launched domestic centrifuge manufacturing, planned a 150,000-square-foot support facility and was selected for a $900 million DOE task order subject to negotiation.

What is still unproven?

Demonstration-scale operation does not automatically translate into economical commercial scale. Centrus must manufacture many centrifuges, construct cascades, secure public and private financing, obtain contract commitments, manage licensing and execute construction. The company’s 2025 results announcement linked planned capacity to a $2.3 billion contingent LEU sales backlog and proposed production of 12 metric tons of HALEU. The word “contingent” is crucial: these commitments depend on Centrus securing substantial investment and actually building capacity.

What gives Centrus a competitive advantage?

The moat is not a consumer brand or a software network effect. It is a combination of regulated technology, specialized facilities, nuclear-quality manufacturing, operating know-how, customer qualifications and government relevance. Uranium enrichment is difficult to enter because the technology is sensitive, licensing is rigorous, capital needs are high and customers demand long-term reliability. Centrus also has relationships with utilities extending over decades and a backlog stretching to 2040.

Technology and policy create unusually high barriers

Who are the main competitors?

Global enrichment competition includes Urenco, Orano and Russia’s TENEX, while China’s enrichment system also contributes to global capacity but is not a conventional Western commercial supplier. Centrus currently competes partly as a marketer and partly as an emerging producer. Urenco has large operating scale in the United States and Europe; Orano is expanding French capacity; TENEX remains a major historical supplier but is constrained by U.S. import restrictions. Centrus’s differentiation is not current scale. It is the combination of U.S. ownership, a domestically controlled centrifuge design and eligibility for national-security missions.

How financially strong is Centrus Energy?

Centrus entered 2026 with exceptional liquidity relative to its historical size, but that liquidity came partly from financing transactions rather than operating cash generation alone. Cash and cash equivalents were $1.868 billion at March 31, 2026, down from $1.957 billion at December 31, 2025. The company also had $336.0 million of inventory and $2.295 billion of current assets at quarter-end. This provides a substantial cushion for engineering, manufacturing and project development.

Cash is both a strength and a valuation complication

Investment income reached $17.0 million in Q1 2026, up from $7.3 million a year earlier, because operating cash was primarily held in money-market accounts. This interest income materially supported net earnings. Analysts should therefore distinguish operating profitability from treasury income. The cash balance reduces financing risk, but the company also carried convertible notes with $1.2075 billion of future principal payments at year-end 2025, concentrated in 2030 and thereafter.

What does capital allocation need to accomplish?

The central allocation decision is how much cash Centrus should commit before government awards and customer contracts become fully funded. Expansion requires centrifuge manufacturing, site infrastructure, cascade construction, licensing and working capital. Management must balance speed against preserving liquidity. Unlike a mature utility, Centrus does not currently center its story on dividends or routine buybacks; reinvestment and project finance dominate the capital-allocation framework.

Who owns Centrus stock, and why does governance matter?

Centrus has a mostly one-share, one-vote Class A structure, but it also has 719,200 Class B shares held by strategic investors. The 2026 proxy statement reported 18,952,387 Class A shares and 719,200 Class B shares outstanding as of March 27, 2026. Class B holders elect one investor-designated director, while Class A holders elect the other directors. This gives strategic investors a formal board channel without broad voting control over ordinary Class A matters.

Why is the Section 382 rights plan relevant?

The proxy also asks shareholders to approve an amended rights agreement designed to protect net operating loss carryforwards and other tax benefits. The plan generally uses a 4.99% ownership threshold, with exceptions and grandfathering provisions. This can constrain accumulation by large holders and is therefore relevant to both governance and valuation: preserving tax assets may be beneficial, but the mechanism can affect takeover dynamics and large-block ownership.

What risks could change the Centrus story?

The company’s upside is tied to a policy-supported rebuild of U.S. enrichment, but the same concentration creates material risk. The LEU business has historically depended on supply from TENEX under a contract extending through 2028. U.S. legislation now bans Russian LEU imports subject to DOE waivers, while Russian actions could also restrict exports. Centrus disclosed that waivers permit certain deliveries already committed to customers, but the legal and geopolitical environment can still disrupt supply, timing and margins.

The largest operating and financial risks

How should researchers interpret the backlog?

Backlog is a strong demand signal but not a guarantee. Technical Solutions backlog includes funded, unfunded and unexercised-option amounts. LEU backlog includes definitive contracts with contingent commitments whose realization depends on financing. A robust analysis should therefore separate fixed delivery obligations, customer prepayments, government-funded work and contingent expansion demand.

Which KPIs and valuation drivers matter most?

Traditional revenue growth and EPS are insufficient because Centrus is simultaneously operating a trading-and-contracting business and building a manufacturing platform. The valuation question is how much current LEU cash generation and cash-on-hand are worth, versus how much probability-adjusted value should be assigned to future domestic enrichment capacity.

How should a DCF treat Centrus?

A single straight-line forecast can be misleading. A more useful framework separates the current LEU franchise, net cash and debt, government contract cash flows, and the probability-weighted value of new LEU and HALEU capacity. Terminal assumptions should reflect geopolitical risk, nuclear-fuel contracting cycles, high capital intensity and the possibility that scarcity pricing normalizes as competitors expand. Comparable-company analysis is also difficult because Centrus combines fuel marketing, sensitive technology and a pre-scale manufacturing project.

What is the key takeaway from Centrus Energy analysis?

Centrus matters because it sits at the intersection of commercial nuclear fuel, U.S. energy security and advanced-reactor deployment. The established LEU segment produced 77.2% of FY2025 revenue and nearly all segment gross profit, while the Technical Solutions segment carries the strategic ambition to restore U.S.-owned enrichment at scale. Q1 2026 demonstrated both sides of the model: stronger government-contract revenue, lower LEU volume, high liquidity and rising technology spending.

For students and researchers, Centrus is a useful case study in how regulation, geopolitics, technology ownership and government procurement can create barriers stronger than ordinary scale economics. For valuation work, the most important next evidence is not simply quarterly EPS. It is the pace at which contingent backlog becomes funded, centrifuge production becomes repeatable, HALEU and LEU capacity receive capital commitments, and the company preserves cash while moving from demonstration to commercial operation.